A new report titled “Flow Cytometry: Products, Technologies and Global Markets” has been published by companiesandmarkets.com.
According to this report, flow cytometry and many other high-throughput technologies have found to be expanding in the a past few years due to investment of the life sciences industry in R&D, especially in stem cell, pharmacogenomics, genomics, and proteomics research. The size and cost of flow cytometry devices is creating a hindrance for the growth of its market, even though increasing potential applications of these devices may handle the problem to some extent. The lack of acceptance and awareness of flow cytology technology is considered as a cause for restricted growth.
This report splits the flow cytometry market into several segments such as technology, software, services, reagents, instruments, end users, and applications. Further, the instrument segment was subdivided into optical systems, measuring systems, immunocytometry products, fluidics, detectors, cell sorters, analyzers, and amplification systems.
The study report comprises 135 pages and offers a comprehensive explanation to the reader regarding the flow cytometry market with forecast and historical information from the year 2010 to 2015. The also provides in-depth data on market landscape with analysis of M&A and collaborative activity, drivers/barriers for growth, opportunities, trends, and other factors that influence the market.
The flow cytology research report also includes the profiles of related companies such as Amnis, Alpco Diagnostics, Santa Cruz Biotechnology, Southern and Biotech Union Biometrica, Advanced Analytical Technologies, Millipore, Beckman Coulter, Alpco Diagnostics, Cell Signaling Technology (CST), Intellicyt, Luminex, Pointcare Technologies, Promega, R&D Systems, Sigma-Aldrich, and several others.
Source: http://www.companiesandmarkets.com/